This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| DST/NRF Centre of Excellence in Biomedical Tuberculosis Research | |
|---|---|
| Name | DST/NRF Centre of Excellence in Biomedical Tuberculosis Research |
| Formation | 2009 |
| Type | Research centre |
| Headquarters | Cape Town |
| Region served | South Africa |
| Parent organization | Department of Science and Technology (South Africa) |
DST/NRF Centre of Excellence in Biomedical Tuberculosis Research The DST/NRF Centre of Excellence in Biomedical Tuberculosis Research is a South African research centre focused on translational Tuberculosis science and clinical interventions. The centre coordinates multidisciplinary teams to address Mycobacterium tuberculosis pathogenesis, drug resistance, vaccine development and diagnostics, linking laboratory science with clinical cohorts. It operates through partnerships with universities, hospitals and international research institutions to influence public health policy and clinical practice.
The centre was established in 2009 following strategic initiatives by the Department of Science and Technology (South Africa) and the National Research Foundation (South Africa) to build capacity in infectious disease research, responding to the intersecting epidemics of HIV/AIDS and Tuberculosis in South Africa. Founding partners included University of Cape Town, Stellenbosch University, University of the Western Cape and South African Medical Research Council, with early leadership drawn from investigators associated with Desmond Tutu HIV Foundation and Groote Schuur Hospital. The formation echoed global efforts seen in initiatives such as the Stop TB Partnership and collaborations with the World Health Organization.
Governance includes an academic steering committee with representatives from partner universities like University of Pretoria, University of the Witwatersrand, University of KwaZulu-Natal, and research councils such as the National Institute for Communicable Diseases. Clinical ties extend to hospitals including Tygerberg Hospital, Groote Schuur Hospital, and King Edward VIII Hospital. International affiliations comprise agreements with institutions like Imperial College London, Harvard Medical School, University of California, San Francisco, Karolinska Institutet, Institut Pasteur, and networks including the European & Developing Countries Clinical Trials Partnership.
Research programs span host–pathogen interactions, molecular diagnostics, pharmacology, immunology, and clinical trials, with projects aligned to priorities from World Health Assembly resolutions and Bill & Melinda Gates Foundation agendas. Translational streams collaborate with groups such as TB Alliance, Global Fund to Fight AIDS, Tuberculosis and Malaria, Wellcome Trust, and United States National Institutes of Health intramural programs. Focus areas include studies involving techniques from next-generation sequencing collaborations with Broad Institute, immunophenotyping akin to work at La Jolla Institute for Immunology, and biomarker discovery paralleling efforts at London School of Hygiene & Tropical Medicine.
The centre maintains biosafety level 3 laboratories comparable to facilities at Centers for Disease Control and Prevention, and shares core platforms with partner institutions including high-throughput sequencing at nodes like Genomics Core Facility models seen at Wellcome Sanger Institute. Clinical research units operate in alignment with good clinical practice standards observed at Clinical Trials Unit (Imperial College London) and employ imaging resources similar to National Institutes of Health Clinical Center setups. Biobanks follow governance frameworks resembling Human Tissue Authority and data management uses secure systems inspired by European Genome-phenome Archive protocols.
Major projects include multi-site clinical trials in collaboration with HIV Prevention Trials Network, cohort studies linked to Africa Health Research Institute, and diagnostic evaluations with partners such as Cepheid and research consortia like RePORT International. Vaccine-related collaboration mirrors partnerships between Aeras and academic groups at Johns Hopkins University, while drug-resistance surveillance engages networks akin to Global Tuberculosis Programme initiatives and partnerships with Pharmacopeia-style consortia. Collaborative capacity-building projects involve associations with African Academy of Sciences, Wellcome Centre for Infectious Diseases Research in Africa, and the Consortium for Advanced Research Training in Africa.
Core funding derives from the Department of Science and Technology (South Africa) and the National Research Foundation (South Africa), supplemented by competitive grants from organizations including Wellcome Trust, Bill & Melinda Gates Foundation, European Commission Horizon 2020, National Institutes of Health, Global Fund to Fight AIDS, Tuberculosis and Malaria, and philanthropic donors like Clinton Health Access Initiative. Project-specific support has been awarded through mechanisms similar to Marie Skłodowska-Curie Actions fellowships, Fogarty International Center awards, and collaborative grants administered with partners such as European & Developing Countries Clinical Trials Partnership.
The centre has produced peer-reviewed publications in journals linked to institutions such as The Lancet, Nature, Science, New England Journal of Medicine, and PLoS Medicine, and contributed data to global surveillance outlets like Global Tuberculosis Report compilations associated with the World Health Organization. Its investigators have received awards and recognition from bodies including the South African Medical Research Council, Royal Society, Academy of Science of South Africa, and international prizes similar to Gates Award-type honors. Alumni and collaborators hold positions at University of Oxford, Columbia University, Yale University, McGill University, and public health agencies including National Institutes of Health and Centers for Disease Control and Prevention, reflecting the centre's role in shaping careers and policy in tuberculosis research.
Category:Research institutes in South Africa Category:Tuberculosis research